APO Research
Talk to an analyst

APO RESEARCH · REPORT

Low Molecular Weight Heparin

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Selected research

Industry Growth & Trends

Global Low Molecular Weight Heparin Industry Growth and Trends Forecast to 2032

21 December 202591 pages

Choose your research edition.

Industry ResearchLow Molecular Weight Heparin Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Low Molecular Weight Heparin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Low Molecular Weight Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Low Molecular Weight Heparin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Low Molecular Weight Heparin Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 35%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Low Molecular Weight Heparin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Low Molecular Weight Heparin market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Low Molecular Weight Heparin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Low Molecular Weight Heparin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Low Molecular Weight Heparin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Low Molecular Weight Heparin Market by Company

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutical

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group

Low Molecular Weight Heparin Segment by Type

Enoxaparin

Dalteparin

Tinzaparin

Fraxiparine

Low Molecular Weight Heparin Segment by Application

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

Low Molecular Weight Heparin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Low Molecular Weight Heparin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Low Molecular Weight Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Enoxaparin Table 2. Major Company of Dalteparin Table 3. Major Company of Tinzaparin Table 4. Major Company of Fraxiparine Table 5. Global Low Molecular Weight Heparin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Low Molecular Weight Heparin Sales by Type (2021-2026) & (MT) Table 7. Global Low Molecular Weight Heparin Sales Market Share in Volume by Type (2021-2026) Table 8. Global Low Molecular Weight Heparin Sales by Type (2021-2026) & (US$ Million) Table 9. Global Low Molecular Weight Heparin Sales Market Share in Value by Type (2021-2026) Table 10. Global Low Molecular Weight Heparin Price by Type (2021-2026) & (USD/MT) Table 11. Global Low Molecular Weight Heparin Sales by Type (2027-2032) & (MT) Table 12. Global Low Molecular Weight Heparin Sales Market Share in Volume by Type (2027-2032) Table 13. Global Low Molecular Weight Heparin Sales by Type (2027-2032) & (US$ Million) Table 14. Global Low Molecular Weight Heparin Sales Market Share in Value by Type (2027-2032) Table 15. Global Low Molecular Weight Heparin Price by Type (2027-2032) & (USD/MT) Table 16. North America Low Molecular Weight Heparin Sales by Type (2021-2026) & (MT) Table 17. North America Low Molecular Weight Heparin Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Low Molecular Weight Heparin Sales by Type (2021-2026) & (MT) Table 19. Europe Low Molecular Weight Heparin Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Low Molecular Weight Heparin Sales by Type (2021-2026) & (MT) Table 21. Asia-Pacific Low Molecular Weight Heparin Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Low Molecular Weight Heparin Sales by Type (2021-2026) & (MT) Table 23. Latin America Low Molecular Weight Heparin Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Low Molecular Weight Heparin Sales by Type (2021-2026) & (MT) Table 25. Middle East and Africa Low Molecular Weight Heparin Sales by Type (2021-2026) & (US$ Million) Table 26. Low Molecular Weight Heparin Industry Trends Table 27. Low Molecular Weight Heparin Industry Drivers Table 28. Low Molecular Weight Heparin Industry Opportunities and Challenges Table 29. Low Molecular Weight Heparin Industry Restraints Table 30. Global Low Molecular Weight Heparin Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Low Molecular Weight Heparin Revenue Market Share by Company (2021-2026) Table 32. Global Low Molecular Weight Heparin Sales by Company (2021-2026) & (MT) Table 33. Global Low Molecular Weight Heparin Sales Share by Company (2021-2026) Table 34. Global Low Molecular Weight Heparin Market Price by Company (2021-2026) & (USD/MT) Table 35. Global Low Molecular Weight Heparin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Low Molecular Weight Heparin Major Company Production Sites and Headquarters Table 37. Global Low Molecular Weight Heparin Company, Product Type & Application Table 38. Global Low Molecular Weight Heparin Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Low Molecular Weight Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Low Molecular Weight Heparin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Low Molecular Weight Heparin Sales by Region (2021-2026) & (MT) Table 43. Global Low Molecular Weight Heparin Sales Market Share in Volume by Region (2021-2026) Table 44. Global Low Molecular Weight Heparin Sales by Region (2021-2026) & (US$ Million) Table 45. Global Low Molecular Weight Heparin Sales Market Share in Value by Region (2021-2026) Table 46. Global Low Molecular Weight Heparin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 47. Global Low Molecular Weight Heparin Sales by Region (2027-2032) & (MT) Table 48. Global Low Molecular Weight Heparin Sales Market Share in Volume by Region (2027-2032) Table 49. Global Low Molecular Weight Heparin Sales by Region (2027-2032) & (US$ Million) Table 50. Global Low Molecular Weight Heparin Sales Market Share in Value by Region (2027-2032) Table 51. Global Low Molecular Weight Heparin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 52. Global Low Molecular Weight Heparin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Low Molecular Weight Heparin Sales by Application (2021-2026) & (MT) Table 54. Global Low Molecular Weight Heparin Sales Market Share in Volume by Application (2021-2026) Table 55. Global Low Molecular Weight Heparin Sales by Application (2021-2026) & (US$ Million) Table 56. Global Low Molecular Weight Heparin Sales Market Share in Value by Application (2021-2026) Table 57. Global Low Molecular Weight Heparin Price by Application (2021-2026) & (USD/MT) Table 58. Global Low Molecular Weight Heparin Sales by Application (2027-2032) & (MT) Table 59. Global Low Molecular Weight Heparin Sales Market Share in Volume by Application (2027-2032) Table 60. Global Low Molecular Weight Heparin Sales by Application (2027-2032) & (US$ Million) Table 61. Global Low Molecular Weight Heparin Sales Market Share in Value by Application (2027-2032) Table 62. Global Low Molecular Weight Heparin Price by Application (2027-2032) & (USD/MT) Table 63. North America Low Molecular Weight Heparin Sales by Application (2021-2026) & (MT) Table 64. North America Low Molecular Weight Heparin Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Low Molecular Weight Heparin Sales by Application (2021-2026) & (MT) Table 66. Europe Low Molecular Weight Heparin Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Low Molecular Weight Heparin Sales by Application (2021-2026) & (MT) Table 68. Asia-Pacific Low Molecular Weight Heparin Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Low Molecular Weight Heparin Sales by Application (2021-2026) & (MT) Table 70. Latin America Low Molecular Weight Heparin Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Low Molecular Weight Heparin Sales by Application (2021-2026) & (MT) Table 72. Middle East and Africa Low Molecular Weight Heparin Sales by Application (2021-2026) & (US$ Million) Table 73. Aspen Company Information Table 74. Aspen Business Overview Table 75. Aspen Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 76. Aspen Low Molecular Weight Heparin Product Portfolio Table 77. Aspen Recent Development Table 78. Sanofi-aventis Company Information Table 79. Sanofi-aventis Business Overview Table 80. Sanofi-aventis Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 81. Sanofi-aventis Low Molecular Weight Heparin Product Portfolio Table 82. Sanofi-aventis Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 86. Pfizer Low Molecular Weight Heparin Product Portfolio Table 87. Pfizer Recent Development Table 88. Opocrin Company Information Table 89. Opocrin Business Overview Table 90. Opocrin Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 91. Opocrin Low Molecular Weight Heparin Product Portfolio Table 92. Opocrin Recent Development Table 93. CSBIO Company Information Table 94. CSBIO Business Overview Table 95. CSBIO Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 96. CSBIO Low Molecular Weight Heparin Product Portfolio Table 97. CSBIO Recent Development Table 98. Dongying Tiandong Pharmaceutical Company Information Table 99. Dongying Tiandong Pharmaceutical Business Overview Table 100. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 101. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio Table 102. Dongying Tiandong Pharmaceutical Recent Development Table 103. Changzhou Qianhong Bio-pharma Company Information Table 104. Changzhou Qianhong Bio-pharma Business Overview Table 105. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 106. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio Table 107. Changzhou Qianhong Bio-pharma Recent Development Table 108. Techdow Company Information Table 109. Techdow Business Overview Table 110. Techdow Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 111. Techdow Low Molecular Weight Heparin Product Portfolio Table 112. Techdow Recent Development Table 113. Yantai Dongcheng Pharmaceutical Group Company Information Table 114. Yantai Dongcheng Pharmaceutical Group Business Overview Table 115. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 116. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio Table 117. Yantai Dongcheng Pharmaceutical Group Recent Development Table 118. North America Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 119. North America Low Molecular Weight Heparin Sales by Country (2021-2026) & (MT) Table 120. North America Low Molecular Weight Heparin Sales Market Share by Country (2021-2026) Table 121. North America Low Molecular Weight Heparin Sales Forecast by Country (2027-2032) & (MT) Table 122. North America Low Molecular Weight Heparin Sales Market Share Forecast by Country (2027-2032) Table 123. North America Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Low Molecular Weight Heparin Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Low Molecular Weight Heparin Market Share by Country (2021-2026) Table 126. North America Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Low Molecular Weight Heparin Market Share Forecast by Country (2027-2032) Table 128. Europe Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 129. Europe Low Molecular Weight Heparin Sales by Country (2021-2026) & (MT) Table 130. Europe Low Molecular Weight Heparin Sales Market Share by Country (2021-2026) Table 131. Europe Low Molecular Weight Heparin Sales Forecast by Country (2027-2032) & (MT) Table 132. Europe Low Molecular Weight Heparin Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Low Molecular Weight Heparin Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Low Molecular Weight Heparin Market Share by Country (2021-2026) Table 136. Europe Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Low Molecular Weight Heparin Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Low Molecular Weight Heparin Sales by Country (2021-2026) & (MT) Table 140. Asia-Pacific Low Molecular Weight Heparin Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Low Molecular Weight Heparin Sales Forecast by Country (2027-2032) & (MT) Table 142. Asia-Pacific Low Molecular Weight Heparin Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Low Molecular Weight Heparin Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Low Molecular Weight Heparin Market Share by Country (2021-2026) Table 146. Asia-Pacific Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Low Molecular Weight Heparin Market Share Forecast by Country (2027-2032) Table 148. Latin America Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 149. Latin America Low Molecular Weight Heparin Sales by Country (2021-2026) & (MT) Table 150. Latin America Low Molecular Weight Heparin Sales Market Share by Country (2021-2026) Table 151. Latin America Low Molecular Weight Heparin Sales Forecast by Country (2027-2032) & (MT) Table 152. Latin America Low Molecular Weight Heparin Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Low Molecular Weight Heparin Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Low Molecular Weight Heparin Market Share by Country (2021-2026) Table 156. Latin America Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Low Molecular Weight Heparin Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Low Molecular Weight Heparin Sales by Country (2021-2026) & (MT) Table 160. Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Low Molecular Weight Heparin Sales Forecast by Country (2027-2032) & (MT) Table 162. Middle East and Africa Low Molecular Weight Heparin Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Low Molecular Weight Heparin Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Low Molecular Weight Heparin Market Share by Country (2021-2026) Table 166. Middle East and Africa Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Low Molecular Weight Heparin Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Low Molecular Weight Heparin Distributors List Table 171. Low Molecular Weight Heparin Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Low Molecular Weight Heparin Image Figure 2. Global Low Molecular Weight Heparin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Low Molecular Weight Heparin Market Size (2021-2032) & (US$ Million) Figure 4. Global Low Molecular Weight Heparin Sales (2021-2032) & (MT) Figure 5. Enoxaparin Image Figure 6. Global Enoxaparin Sales YoY Growth (2021-2032) & (MT) Figure 7. Dalteparin Image Figure 8. Global Dalteparin Sales YoY Growth (2021-2032) & (MT) Figure 9. Tinzaparin Image Figure 10. Global Tinzaparin Sales YoY Growth (2021-2032) & (MT) Figure 11. Fraxiparine Image Figure 12. Global Fraxiparine Sales YoY Growth (2021-2032) & (MT) Figure 13. Global Low Molecular Weight Heparin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Low Molecular Weight Heparin Market Share by Type 2025 VS 2032 Figure 15. North America Low Molecular Weight Heparin Sales Market Share in Volume by Type in 2025 Figure 16. North America Low Molecular Weight Heparin Sales Market Share in Value by Type in 2025 Figure 17. Europe Low Molecular Weight Heparin Sales Market Share in Volume by Type in 2025 Figure 18. Europe Low Molecular Weight Heparin Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Low Molecular Weight Heparin Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Low Molecular Weight Heparin Sales Market Share in Value by Type in 2025 Figure 21. Latin America Low Molecular Weight Heparin Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Low Molecular Weight Heparin Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Low Molecular Weight Heparin Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Low Molecular Weight Heparin Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Low Molecular Weight Heparin Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Treatment of Venous Thromboembolism Image Figure 28. Global Treatment of Venous Thromboembolism Sales YoY Growth (2021-2032) & (MT) Figure 29. Complications of Pregnancy Image Figure 30. Global Complications of Pregnancy Sales YoY Growth (2021-2032) & (MT) Figure 31. Cardioversion of Atrial Fibrillation/Flutter Image Figure 32. Global Cardioversion of Atrial Fibrillation/Flutter Sales YoY Growth (2021-2032) & (MT) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 35. Global Low Molecular Weight Heparin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Low Molecular Weight Heparin Market Share by Application 2025 VS 2032 Figure 37. North America Low Molecular Weight Heparin Sales Market Share in Volume by Application in 2025 Figure 38. North America Low Molecular Weight Heparin Sales Market Share in Value by Application in 2025 Figure 39. Europe Low Molecular Weight Heparin Sales Market Share in Volume by Application in 2025 Figure 40. Europe Low Molecular Weight Heparin Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Low Molecular Weight Heparin Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Low Molecular Weight Heparin Sales Market Share in Value by Application in 2025 Figure 43. Latin America Low Molecular Weight Heparin Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Low Molecular Weight Heparin Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Low Molecular Weight Heparin Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Low Molecular Weight Heparin Sales Market Share in Value by Application in 2025 Figure 47. North America Low Molecular Weight Heparin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. North America Low Molecular Weight Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Low Molecular Weight Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Low Molecular Weight Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Low Molecular Weight Heparin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Europe Low Molecular Weight Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Low Molecular Weight Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Low Molecular Weight Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Low Molecular Weight Heparin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Asia-Pacific Low Molecular Weight Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Low Molecular Weight Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Low Molecular Weight Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Low Molecular Weight Heparin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Latin America Low Molecular Weight Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Low Molecular Weight Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Low Molecular Weight Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Low Molecular Weight Heparin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 64. Middle East and Africa Low Molecular Weight Heparin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Low Molecular Weight Heparin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Low Molecular Weight Heparin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Low Molecular Weight Heparin Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Low Molecular Weight Heparin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Enoxaparin
  • Dalteparin
  • Tinzaparin
  • Fraxiparine
Applications
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Others
Companies covered
  • Aspen
  • Sanofi-aventis
  • Pfizer
  • Opocrin
  • CSBIO
  • Dongying Tiandong Pharmaceutical
  • Changzhou Qianhong Bio-pharma
  • Techdow
  • Yantai Dongcheng Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Low Molecular Weight Heparin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Low Molecular Weight Heparin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Low Molecular Weight Heparin Market by Type
  6. 1.3.1 Enoxaparin
  7. 1.3.2 Dalteparin
  8. 1.3.3 Tinzaparin
  9. 1.3.4 Fraxiparine
  10. 1.4 Global Low Molecular Weight Heparin Market Size by Type
  11. 1.4.1 Global Low Molecular Weight Heparin Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Low Molecular Weight Heparin Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Low Molecular Weight Heparin Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Low Molecular Weight Heparin Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Low Molecular Weight Heparin Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Low Molecular Weight Heparin Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Low Molecular Weight Heparin Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Low Molecular Weight Heparin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Low Molecular Weight Heparin Industry Trends
  2. 2.2 Low Molecular Weight Heparin Industry Drivers
  3. 2.3 Low Molecular Weight Heparin Industry Opportunities and Challenges
  4. 2.4 Low Molecular Weight Heparin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Low Molecular Weight Heparin Revenue (2021-2026)
  2. 3.2 Global Top Players by Low Molecular Weight Heparin Sales (2021-2026)
  3. 3.3 Global Top Players by Low Molecular Weight Heparin Price (2021-2026)
  4. 3.4 Global Low Molecular Weight Heparin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Low Molecular Weight Heparin Major Company Production Sites & Headquarters
  6. 3.6 Global Low Molecular Weight Heparin Company, Product Type & Application
  7. 3.7 Global Low Molecular Weight Heparin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Low Molecular Weight Heparin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Low Molecular Weight Heparin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Low Molecular Weight Heparin Tier 1, Tier 2, and Tier 3
4 Low Molecular Weight Heparin Regional Status and Outlook
  1. 4.1 Global Low Molecular Weight Heparin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Low Molecular Weight Heparin Historic Market Size by Region
  3. 4.2.1 Global Low Molecular Weight Heparin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Low Molecular Weight Heparin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Low Molecular Weight Heparin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Low Molecular Weight Heparin Forecasted Market Size by Region
  7. 4.3.1 Global Low Molecular Weight Heparin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Low Molecular Weight Heparin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Low Molecular Weight Heparin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Low Molecular Weight Heparin by Application
  1. 5.1 Low Molecular Weight Heparin Market by Application
  2. 5.1.1 Treatment of Venous Thromboembolism
  3. 5.1.2 Complications of Pregnancy
  4. 5.1.3 Cardioversion of Atrial Fibrillation/Flutter
  5. 5.1.4 Others
  6. 5.2 Global Low Molecular Weight Heparin Market Size by Application
  7. 5.2.1 Global Low Molecular Weight Heparin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Low Molecular Weight Heparin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Low Molecular Weight Heparin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Low Molecular Weight Heparin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Low Molecular Weight Heparin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Low Molecular Weight Heparin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Low Molecular Weight Heparin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Low Molecular Weight Heparin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aspen
  2. 6.1.1 Aspen Company Information
  3. 6.1.2 Aspen Business Overview
  4. 6.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aspen Low Molecular Weight Heparin Product Portfolio
  6. 6.1.5 Aspen Recent Developments
  7. 6.2 Sanofi-aventis
  8. 6.2.1 Sanofi-aventis Company Information
  9. 6.2.2 Sanofi-aventis Business Overview
  10. 6.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi-aventis Low Molecular Weight Heparin Product Portfolio
  12. 6.2.5 Sanofi-aventis Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Low Molecular Weight Heparin Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Opocrin
  20. 6.4.1 Opocrin Company Information
  21. 6.4.2 Opocrin Business Overview
  22. 6.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Opocrin Low Molecular Weight Heparin Product Portfolio
  24. 6.4.5 Opocrin Recent Developments
  25. 6.5 CSBIO
  26. 6.5.1 CSBIO Company Information
  27. 6.5.2 CSBIO Business Overview
  28. 6.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSBIO Low Molecular Weight Heparin Product Portfolio
  30. 6.5.5 CSBIO Recent Developments
  31. 6.6 Dongying Tiandong Pharmaceutical
  32. 6.6.1 Dongying Tiandong Pharmaceutical Company Information
  33. 6.6.2 Dongying Tiandong Pharmaceutical Business Overview
  34. 6.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio
  36. 6.6.5 Dongying Tiandong Pharmaceutical Recent Developments
  37. 6.7 Changzhou Qianhong Bio-pharma
  38. 6.7.1 Changzhou Qianhong Bio-pharma Company Information
  39. 6.7.2 Changzhou Qianhong Bio-pharma Business Overview
  40. 6.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio
  42. 6.7.5 Changzhou Qianhong Bio-pharma Recent Developments
  43. 6.8 Techdow
  44. 6.8.1 Techdow Company Information
  45. 6.8.2 Techdow Business Overview
  46. 6.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Techdow Low Molecular Weight Heparin Product Portfolio
  48. 6.8.5 Techdow Recent Developments
  49. 6.9 Yantai Dongcheng Pharmaceutical Group
  50. 6.9.1 Yantai Dongcheng Pharmaceutical Group Company Information
  51. 6.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
  52. 6.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio
  54. 6.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments
7 North America by Country
  1. 7.1 North America Low Molecular Weight Heparin Sales by Country
  2. 7.1.1 North America Low Molecular Weight Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Low Molecular Weight Heparin Sales by Country (2021-2026)
  4. 7.1.3 North America Low Molecular Weight Heparin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Low Molecular Weight Heparin Market Size by Country
  6. 7.2.1 North America Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Low Molecular Weight Heparin Market Size by Country (2021-2026)
  8. 7.2.3 North America Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Low Molecular Weight Heparin Sales by Country
  2. 8.1.1 Europe Low Molecular Weight Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Low Molecular Weight Heparin Sales by Country (2021-2026)
  4. 8.1.3 Europe Low Molecular Weight Heparin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Low Molecular Weight Heparin Market Size by Country
  6. 8.2.1 Europe Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Low Molecular Weight Heparin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Low Molecular Weight Heparin Sales by Country
  2. 9.1.1 Asia-Pacific Low Molecular Weight Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Low Molecular Weight Heparin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Low Molecular Weight Heparin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Low Molecular Weight Heparin Market Size by Country
  6. 9.2.1 Asia-Pacific Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Low Molecular Weight Heparin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Low Molecular Weight Heparin Sales by Country
  2. 10.1.1 South America Low Molecular Weight Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Low Molecular Weight Heparin Sales by Country (2021-2026)
  4. 10.1.3 South America Low Molecular Weight Heparin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Low Molecular Weight Heparin Market Size by Country
  6. 10.2.1 South America Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Low Molecular Weight Heparin Market Size by Country (2021-2026)
  8. 10.2.3 South America Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Low Molecular Weight Heparin Sales by Country
  2. 11.1.1 Middle East and Africa Low Molecular Weight Heparin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Low Molecular Weight Heparin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Low Molecular Weight Heparin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Low Molecular Weight Heparin Market Size by Country
  6. 11.2.1 Middle East and Africa Low Molecular Weight Heparin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Low Molecular Weight Heparin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Low Molecular Weight Heparin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Low Molecular Weight Heparin Value Chain Analysis
  2. 12.1.1 Low Molecular Weight Heparin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Low Molecular Weight Heparin Production Mode & Process
  7. 12.2 Low Molecular Weight Heparin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Low Molecular Weight Heparin Distributors
  10. 12.2.3 Low Molecular Weight Heparin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst